Mediterranean Towers Past Earnings Performance
Past criteria checks 4/6
Mediterranean Towers has been growing earnings at an average annual rate of 32.6%, while the Healthcare industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 6.3% per year. Mediterranean Towers's return on equity is 16%, and it has net margins of 91.6%.
Key information
32.6%
Earnings growth rate
31.6%
EPS growth rate
| Healthcare Industry Growth | 14.9% |
| Revenue growth rate | 6.3% |
| Return on equity | 16.0% |
| Net Margin | 91.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
We Like These Underlying Return On Capital Trends At Mediterranean Towers (TLV:MDTR)
Apr 18
There May Be Underlying Issues With The Quality Of Mediterranean Towers' (TLV:MDTR) Earnings
Apr 03These 4 Measures Indicate That Mediterranean Towers (TLV:MDTR) Is Using Debt Extensively
Dec 05A Look At The Intrinsic Value Of Mediterranean Towers Ltd. (TLV:MDTR)
Oct 09Mediterranean Towers (TLV:MDTR) Has More To Do To Multiply In Value Going Forward
May 06Does It Make Sense To Buy Mediterranean Towers Ltd. (TLV:MDTR) For Its Yield?
Apr 15Estimating The Fair Value Of Mediterranean Towers Ltd. (TLV:MDTR)
Mar 25Here's Why Mediterranean Towers (TLV:MDTR) Has A Meaningful Debt Burden
Mar 10What Type Of Shareholders Own The Most Number of Mediterranean Towers Ltd. (TLV:MDTR) Shares?
Feb 20
Has Mediterranean Towers (TLV:MDTR) Got What It Takes To Become A Multi-Bagger?
Jan 21Does Mediterranean Towers Ltd.'s (TLV:MDTR) Weak Fundamentals Mean That The Market Could Correct Its Share Price?
Jan 06How Should Investors Feel About Mediterranean Towers' (TLV:MDTR) CEO Remuneration?
Dec 22These 4 Measures Indicate That Mediterranean Towers (TLV:MDTR) Is Using Debt Extensively
Dec 08We Wouldn't Rely On Mediterranean Towers's (TLV:MDTR) Statutory Earnings As A Guide
Nov 24Revenue & Expenses BreakdownBeta
How Mediterranean Towers makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 241 | 221 | 53 | 0 |
| 30 Sep 23 | 242 | 145 | 55 | 0 |
| 30 Jun 23 | 243 | 168 | 56 | 0 |
| 31 Mar 23 | 239 | 157 | 57 | 0 |
| 31 Dec 22 | 234 | 121 | 58 | 0 |
| 30 Sep 22 | 229 | 370 | 59 | 0 |
| 30 Jun 22 | 223 | 339 | 56 | 0 |
| 31 Mar 22 | 217 | 305 | 54 | 0 |
| 31 Dec 21 | 213 | 297 | 53 | 0 |
| 30 Sep 21 | 208 | 14 | 50 | 0 |
| 30 Jun 21 | 207 | 6 | 52 | 0 |
| 31 Mar 21 | 205 | 13 | 47 | 0 |
| 31 Dec 20 | 207 | -13 | 47 | 0 |
| 30 Sep 20 | 207 | 60 | 48 | 0 |
| 30 Jun 20 | 205 | 68 | 45 | 0 |
| 31 Mar 20 | 201 | 56 | 48 | 0 |
| 31 Dec 19 | 195 | 81 | 47 | 0 |
| 30 Sep 19 | 189 | 52 | 44 | 0 |
| 30 Jun 19 | 183 | 67 | 41 | 0 |
| 31 Mar 19 | 179 | 73 | 41 | 0 |
| 31 Dec 18 | 175 | 63 | 39 | 0 |
| 30 Sep 18 | 171 | 46 | 39 | 0 |
| 30 Jun 18 | 165 | 63 | 42 | 0 |
| 31 Mar 18 | 161 | 78 | 41 | 0 |
| 31 Dec 17 | 155 | 90 | 44 | 0 |
| 30 Sep 17 | 149 | 103 | 43 | 0 |
| 30 Jun 17 | 143 | 82 | 42 | 0 |
| 31 Mar 17 | 137 | 122 | 42 | 0 |
| 31 Dec 16 | 131 | 126 | 39 | 0 |
| 30 Sep 16 | 128 | 161 | 39 | 0 |
| 30 Jun 16 | 126 | 153 | 38 | 0 |
| 31 Mar 16 | 124 | 98 | 38 | 0 |
| 31 Dec 15 | 123 | 104 | 36 | 0 |
| 30 Sep 15 | 122 | 50 | 37 | 0 |
| 30 Jun 15 | 121 | 47 | 35 | 0 |
| 31 Mar 15 | 120 | 52 | 33 | 0 |
| 31 Dec 14 | 120 | 14 | 31 | 0 |
| 30 Sep 14 | 119 | -10 | 27 | 0 |
| 30 Jun 14 | 118 | 60 | 28 | 0 |
| 31 Mar 14 | 117 | 64 | 28 | 0 |
| 31 Dec 13 | 116 | 75 | 28 | 0 |
| 30 Sep 13 | 116 | 98 | 30 | 0 |
Quality Earnings: MDTR has a large one-off gain of ₪366.9M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: MDTR's current net profit margins (91.6%) are higher than last year (51.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MDTR's earnings have grown significantly by 32.6% per year over the past 5 years.
Accelerating Growth: MDTR's earnings growth over the past year (82.4%) exceeds its 5-year average (32.6% per year).
Earnings vs Industry: MDTR earnings growth over the past year (82.4%) exceeded the Healthcare industry 3.1%.
Return on Equity
High ROE: MDTR's Return on Equity (16%) is considered low.